Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in.
Divided FDA panel urges more Avandia warnings, restrictions
Large group of members votes to pull drug from market entirely
WASHINGTON - In a fractured vote Wednesday, a significant number of members of an advisory committee for the Food and Drug Administration voted in favor of removing the controversial diabetes drug Avandia from the market in light of a reported increased risk of heart attack and other health problems.